加载中
NASDAQHealthcareMedical - Devices
最新数据
US$0.77
−US$0.02 · -2.53%
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
前收盘价
US$0.77
−US$0.02 · -2.53%
盘中时间采用ET。市场数据可能有所延迟。
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
日内区间
当前US$0.77
52周区间
当前US$0.77
盘中时间采用ET。市场数据可能有所延迟。
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
日内区间
当前US$0.77
52周区间
当前US$0.77
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2253.7万 USD | 3703.71万 USD | 3145.79万 USD | 3509.12万 USD | 2772.24万 USD |
| 销货成本 | 365.33万 USD | 438.34万 USD | 422.74万 USD | 705.43万 USD | 454.42万 USD |
| 毛利 | 1888.37万 USD | 3265.37万 USD | 2723.05万 USD | 2803.69万 USD | 2317.82万 USD |
| 研究与开发 | 2013.1万 USD | 617.44万 USD | 427.49万 USD | 385.94万 USD | 104.01万 USD |
| 销售、一般及管理费用 | 2438.35万 USD | 996.43万 USD | 1109.39万 USD | 1054.57万 USD | 1022.09万 USD |
| 营业费用 | 4442.11万 USD | 1733.87万 USD | 1536.88万 USD | 1302.97万 USD | 975.77万 USD |
| 利息收入 | — | 393 USD | — | 8553 USD | 2326 USD |
| 利息支出 | 73.74万 USD | 57.68万 USD | 28.43万 USD | 29.93万 USD | 15.39万 USD |
| 折旧和摊销 | 110.41万 USD | 150.74万 USD | 138.08万 USD | 147万 USD | 139.97万 USD |
| 营业利润 | −2553.74万 USD | 1531.5万 USD | 1186.17万 USD | 1363.17万 USD | 1191.72万 USD |
| 净利润 | −2727.8万 USD | 1245.34万 USD | 1054.6万 USD | 1256.88万 USD | 1167.66万 USD |
公司数据更新于 2026年10月11日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
